Clinical Trials Browser

Phase 2 × Neuroendocrine Tumors × Sorafenib × Clear all

NCT00605566 2019-02-19

Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors

Phase 2 Completed

22 enrolled 10 charts

Neuroendocrine Tumors